These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29746504)

  • 1. Controlling epidemics with transmissible vaccines.
    Nuismer SL; May R; Basinski A; Remien CH
    PLoS One; 2018; 13(5):e0196978. PubMed ID: 29746504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization, epidemic transitions, and unpredictability of multistrain epidemics with an underlying genotype network.
    Williams BJM; St-Onge G; Hébert-Dufresne L
    PLoS Comput Biol; 2021 Feb; 17(2):e1008606. PubMed ID: 33566810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments.
    Noad RJ; Simpson K; Fooks AR; Hewson R; Gilbert SC; Stevens MP; Hosie MJ; Prior J; Kinsey AM; Entrican G; Simpson A; Whitty CJM; Carroll MW
    Vaccine; 2019 Oct; 37(43):6241-6247. PubMed ID: 31522809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Importance of Domestic Vaccine Manufacturing Centers: An Overview of Immunization Programs, Vaccine Manufacture, and Distribution.
    Rey-Jurado E; Tapia F; Muñoz-Durango N; Lay MK; Carreño LJ; Riedel CA; Bueno SM; Genzel Y; Kalergis AM
    Front Immunol; 2018; 9():26. PubMed ID: 29403503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fortresses against infection: time for new defences?
    Stanwell-Smith R
    Perspect Public Health; 2015 Nov; 135(6):266-7. PubMed ID: 26543135
    [No Abstract]   [Full Text] [Related]  

  • 6. Funding vaccines for emerging infectious diseases.
    Wong G; Qiu X
    Hum Vaccin Immunother; 2018 Jul; 14(7):1760-1762. PubMed ID: 29194012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eradicating infectious disease using weakly transmissible vaccines.
    Nuismer SL; Althouse BM; May R; Bull JJ; Stromberg SP; Antia R
    Proc Biol Sci; 2016 Oct; 283(1841):. PubMed ID: 27798311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Mitigation and Control Policies in Realistic Epidemic Models Accounting for Household Transmission Dynamics.
    Alarid-Escudero F; Andrews JR; Goldhaber-Fiebert JD
    Med Decis Making; 2024 Jan; 44(1):5-17. PubMed ID: 37953597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the impact of epidemic severity on network immunization algorithms.
    Shams B; Khansari M
    Theor Popul Biol; 2015 Dec; 106():83-93. PubMed ID: 26505554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the impact of vaccine hesitancy on an emerging infectious disease: a mathematical and numerical analysis.
    Hewage IM; Church KEM; Schwartz EJ
    J Biol Dyn; 2024 Dec; 18(1):2298988. PubMed ID: 38174737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention to maximise the probability of epidemic fade-out.
    Ballard PG; Bean NG; Ross JV
    Math Biosci; 2017 Nov; 293():1-10. PubMed ID: 28804021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemic prevalence information on social networks can mediate emergent collective outcomes in voluntary vaccine schemes.
    Sharma A; Menon SN; Sasidevan V; Sinha S
    PLoS Comput Biol; 2019 May; 15(5):e1006977. PubMed ID: 31120877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient control of epidemics spreading on networks: balance between treatment and recovery.
    Oleś K; Gudowska-Nowak E; Kleczkowski A
    PLoS One; 2013; 8(6):e63813. PubMed ID: 23750205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines for epidemic infections and the role of CEPI.
    Plotkin SA
    Hum Vaccin Immunother; 2017 Dec; 13(12):2755-2762. PubMed ID: 28375764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equal graph partitioning on estimated infection network as an effective epidemic mitigation measure.
    Hadidjojo J; Cheong SA
    PLoS One; 2011; 6(7):e22124. PubMed ID: 21799777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple model for behaviour change in epidemics.
    Brauer F
    BMC Public Health; 2011 Feb; 11 Suppl 1(Suppl 1):S3. PubMed ID: 21356132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine Effects on Heterogeneity in Susceptibility and Implications for Population Health Management.
    Langwig KE; Wargo AR; Jones DR; Viss JR; Rutan BJ; Egan NA; Sá-Guimarães P; Kim MS; Kurath G; Gomes MGM; Lipsitch M
    mBio; 2017 Nov; 8(6):. PubMed ID: 29162706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of epidemic spreading process on multiplex networks via active immunization.
    Li Z; Zhu P; Zhao D; Deng Z; Wang Z
    Chaos; 2019 Jul; 29(7):073111. PubMed ID: 31370413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study.
    Gouglas D; Thanh Le T; Henderson K; Kaloudis A; Danielsen T; Hammersland NC; Robinson JM; Heaton PM; Røttingen JA
    Lancet Glob Health; 2018 Dec; 6(12):e1386-e1396. PubMed ID: 30342925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemic spreading on interconnected networks.
    Saumell-Mendiola A; Serrano MÁ; Boguñá M
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Aug; 86(2 Pt 2):026106. PubMed ID: 23005824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.